On May, 2 Analysts See $0.11 EPS for Allscripts Healthcare Solutions, Inc. (MDRX)

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Corporate Logo
Big Money Sentiment increased to 0.95 in Q4 2018. It has change of 0.07, from 2018Q3’s 0.88. The ratio improved due to Allscripts Healthcare Solutions, Inc. positioning: 32 sold and 65 reduced. 30 funds amassed stakes and 62 increased stakes. Investors holded 170.90 million in 2018Q3 but now own 170.44 million shares or 0.27% less.
Fisher Asset Mgmt Limited Liability Corporation accumulated 5.01 million shs or 0.07% of the stock. Mesirow Financial Inv Mngmt holds 0.97% or 749,265 shs. North Star Asset has 0.59% invested in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Prudential Financial Incorporated accumulated 116,625 shs. Great West Life Assurance Commerce Can holds 0% of its capital in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) for 105,315 shs. D E Shaw And reported 3.39M shs stake. Boston Advsrs Ltd Liability reported 0.11% stake. Blackrock reported 20.39M shs. Meeder Asset Mgmt owns 3,368 shs or 0% of their US capital. Ameriprise Inc owns 1.13M shs. Victory Cap reported 0.02% stake. Panagora Asset Mgmt Inc reported 57,937 shs. Canada Pension Plan Inv Board holds 0% in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) or 82,200 shs. Employees Retirement Systems Of Ohio has invested 0.01% of its capital in Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Qs Investors Ltd Liability accumulated 12,337 shs or 0% of the stock.

Allscripts Healthcare Solutions, Inc. registered $170,721 net activity with 5 buys and 2 selling transactions since December 12, 2018. On Friday, December 14 Aspinall Mara G. also bought $10,006 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX). Garrison Greg also bought $9,798 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Thursday, December 13. JUDGE JONATHAN also bought $99,841 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) on Friday, December 14. On Friday, January 18 $72,000 worth of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was sold by Farley Brian. Spruill Yancey L. had bought 12,000 shs worth $120,840. The insider Poulton Richard J. sold 60,000 shs worth $589,233.

On May, 2 WallStreet anticipated Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)’s earnings release, according to Zacks. Analysts predict $0.11 EPS. That’s $0.00 or 0.00 % from 2018’s earnings of $0.11. This could be $18.85M profit for MDRX assuming the current $0.11 EPS will become reality. Analysts at Wall Street see Allscripts Healthcare Solutions, Inc.’s -31.25 % negative EPS growth compared to $0.16 EPS for previous quarter. The stock increased 0.83% or $0.08 during the last trading session, reaching $9.67.Allscripts Healthcare Solutions, Inc. has volume of 941,630 shares. Since April 8, 2018 MDRX has declined 22.79% and is downtrending. MDRX underperformed the S&P 500 by 27.16%.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Ratings Coverage

A total of 9 analysts rate Allscripts Healthcare (NASDAQ:MDRX) as follows: 4 “Buy”, 4 “Hold” and 1 “Sell”. Š¢herefore 44% are bullish. (NASDAQ:MDRX) has 15 ratings reports on Apr 8, 2019 according to StockzIntelligence. On Friday, November 2 the stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Neutral” rating given by Cantor Fitzgerald. On Friday, January 18 the firm has “Overweight” rating by KeyBanc Capital Markets given. On Wednesday, November 14 the stock of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) has “Hold” rating given by Argus Research. On Monday, February 25 Morgan Stanley maintained Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) rating. Morgan Stanley has “Sell” rating and $9 target. On Friday, November 2 the firm has “Buy” rating given by Citigroup. On Friday, November 2 the rating was maintained by Robert W. Baird with “Outperform”. The company rating was maintained by Bank of America on Friday, November 2. On Friday, November 2 the stock has “Neutral” rating by JP Morgan. On Friday, February 22 the firm has “Neutral” rating by Citigroup given. On Friday, February 22 the rating was maintained by Cowen & Co with “Buy”.

Allscripts Healthcare Solutions, Inc. provides information technology and services to healthcare organizations in the United States, Canada, and internationally.The firm is valued at $1.66 billion. It offers electronic health records, connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions.4.68 is the P/E ratio. The company??s Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services.

For more Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) news announced recently go to: Globenewswire.com, Globenewswire.com, Nasdaq.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “Alfardan Medical with Northwestern Medicine select Allscripts – GlobeNewswire” announced on March 11, 2019, “Allscripts to present at the 2018 Cantor Fitzgerald Global Healthcare Conference – GlobeNewswire” on October 01, 2018, “Allscripts to Fortify Middle East Foothold With New Project – Nasdaq” with a publish date: March 13, 2019, “Allscripts announces third quarter 2018 results Nasdaq:MDRX – GlobeNewswire” and the last “Allscripts to provide ambulatory care services in Qatar – Seeking Alpha” with publication date: March 11, 2019.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.